Home/Filings/4/0001641172-25-001180
4//SEC Filing

Liu James Yang 4

Accession 0001641172-25-001180

CIK 0001642380other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:05 PM ET

Size

8.1 KB

Accession

0001641172-25-001180

Insider Transaction Report

Form 4
Period: 2025-03-26
Liu James Yang
VP ACCT, Cntlr, Treasurer, PAO
Transactions
  • Award

    Option to Purchase Common Stock

    2025-03-26+10,00010,000 total
    Exercise: $3.18Exp: 2035-03-26Common Stock (10,000 underlying)
  • Award

    Restricted Stock Units

    2025-03-26+18,86718,867 total
    Exercise: $0.00Common Stock (18,867 underlying)
Footnotes (2)
  • [F1]33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
  • [F2]33 and 1/3% of the restricted stock units will vest on each of the one-, two- and three-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001944774

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:05 PM ET
Size
8.1 KB